Literature DB >> 15932927

Short-term stimulation of lipogenesis by 3,5-L-diiodothyronine in cultured rat hepatocytes.

Anna M Giudetti1, Monica Leo, Math J H Geelen, Gabriele V Gnoni.   

Abstract

Short-term effects of 3,5-l-diiodothyronine (T2) on lipid biosynthesis were studied in cultured hepatocytes from hypothyroid rats. A comparison with the effects of T3 was routinely carried out. After T2 addition to cell cultures, a distinct stimulation of fatty acid and cholesterol syntheses, measured as incorporation of [1-14C]acetate into these lipid fractions, was observed. The T2 dose-dependent effect on both metabolic pathways, already detectable at 10(-8)-10(-9) M, reached a 2-fold stimulation at 10(-5) M T2. At this concentration, the stimulatory effect was evident within 1 h of T2 addition to the hepatocytes and increased with time up to the length of the experimental period of 4 h. T2 stimulation of lipogenesis was also confirmed by incubating hepatocytes with [3H]H2O, used as an independent index of lipogenic activity. The effects of T2 are rather specific as 3,3',5,5'-tetraiodo-D-thyronine and 3,5-diiodo-L-tyrosine were practically ineffective on both fatty acid and cholesterol synthesis. Analysis of various lipid fractions showed that T2 addition to the cells produced a significant stimulation of the incorporation of newly synthesized fatty acids into both neutral and polar lipids. By comparing the effects induced by T2 with those seen in the presence of T3, it appeared that T2 was able to mimic T3 effects. Experiments conducted in the presence of cycloheximide, a protein synthesis inhibitor, indicated that the T2 stimulatory effect on fatty acid and cholesterol synthesis was essentially independent of protein synthesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15932927     DOI: 10.1210/en.2005-0345

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

1.  3,5-diiodo-L-thyronine increases FoF1-ATP synthase activity and cardiolipin level in liver mitochondria of hypothyroid rats.

Authors:  Alessandro Cavallo; Antonio Gnoni; Elena Conte; Luisa Siculella; Franco Zanotti; Sergio Papa; Gabriele Vincenzo Gnoni
Journal:  J Bioenerg Biomembr       Date:  2011-07-08       Impact factor: 2.945

2.  Insulin- and leptin-regulated fatty acid uptake plays a key causal role in hepatic steatosis in mice with intact leptin signaling but not in ob/ob or db/db mice.

Authors:  Fengxia Ge; Shengli Zhou; Chunguang Hu; Harrison Lobdell; Paul D Berk
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-07-01       Impact factor: 4.052

Review 3.  Lipid lowering effects of iodothyronines: In vivo and in vitro studies on rat liver.

Authors:  Laura Vergani
Journal:  World J Hepatol       Date:  2014-04-27

4.  Rapid down-regulation of hepatic lipid metabolism by phenolic fraction from extra virgin olive oil.

Authors:  Paola Priore; Donatella Caruso; Luisa Siculella; Gabriele V Gnoni
Journal:  Eur J Nutr       Date:  2014-10-09       Impact factor: 5.614

5.  American Thyroid Association Guide to investigating thyroid hormone economy and action in rodent and cell models.

Authors:  Antonio C Bianco; Grant Anderson; Douglas Forrest; Valerie Anne Galton; Balázs Gereben; Brian W Kim; Peter A Kopp; Xiao Hui Liao; Maria Jesus Obregon; Robin P Peeters; Samuel Refetoff; David S Sharlin; Warner S Simonides; Roy E Weiss; Graham R Williams
Journal:  Thyroid       Date:  2013-12-12       Impact factor: 6.568

Review 6.  Action of Thyroid Hormones, T3 and T2, on Hepatic Fatty Acids: Differences in Metabolic Effects and Molecular Mechanisms.

Authors:  Fabrizio Damiano; Alessio Rochira; Antonio Gnoni; Luisa Siculella
Journal:  Int J Mol Sci       Date:  2017-03-31       Impact factor: 5.923

7.  3,5-Diiodo-L-thyronine administration to hypothyroid rats rapidly enhances fatty acid oxidation rate and bioenergetic parameters in liver cells.

Authors:  Alessandro Cavallo; Paola Priore; Gabriele Vincenzo Gnoni; Sergio Papa; Franco Zanotti; Antonio Gnoni
Journal:  PLoS One       Date:  2013-01-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.